Recombinant Mouse G protein-activated inward rectifier potassium channel 2 (Kcnj6)

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Mouse G Protein-Activated Inward Rectifier Potassium Channel 2 (Kcnj6)

Recombinant Mouse G protein-activated inward rectifier potassium channel 2, encoded by the Kcnj6 gene, is a crucial component of the G protein-gated inwardly rectifying potassium (GIRK) channels. GIRK channels play a pivotal role in regulating neuronal excitability by hyperpolarizing the cell membrane in response to the activation of G protein-coupled receptors (GPCRs) . The Kcnj6 gene specifically codes for the GIRK2 subunit, which is involved in forming heteromeric channels with other GIRK subunits to modulate potassium conductance across cell membranes.

Structure and Function of GIRK2 Channels

GIRK channels, including those formed by the GIRK2 subunit, are activated by the G protein βγ subunit (Gβγ) released from the heterotrimeric G protein complex upon GPCR stimulation . The activation process involves a conformational change in the channel structure, facilitated by the binding of Gβγ subunits and the signaling lipid phosphatidylinositol 4,5-bisphosphate (PIP2) . PIP2 is essential for channel activation, as it increases the affinity of the channel for Gβγ .

Table 1: Key Features of GIRK2 Channels

FeatureDescription
GeneKcnj6
ProteinGIRK2
FunctionHyperpolarizes neurons by increasing potassium conductance
ActivationGβγ subunits and PIP2
RoleRegulates neuronal excitability

Research Findings and Implications

Recent studies have highlighted the importance of GIRK channels in neurological disorders. For instance, mutations in the Kcnj6 gene have been associated with severe hyperkinetic movement disorders and developmental delays . These mutations can alter the function of GIRK2 channels, leading to aberrant basal inward currents and changes in ion selectivity .

Table 2: Clinical Implications of GIRK2 Mutations

MutationClinical Implication
Leu171ArgSevere hyperkinetic movement disorder, developmental delay
Weaver mutationSimilar to Leu171Arg, affects channel function

Therapeutic Potential

GIRK channels, including those involving the GIRK2 subunit, are potential therapeutic targets for treating neurological conditions such as epilepsy, Parkinson's disease, and drug addiction . Modulating GIRK channel activity could provide new strategies for managing these disorders by influencing neuronal excitability and synaptic transmission.

Table 3: Potential Therapeutic Applications

ConditionPotential Role of GIRK Channels
EpilepsyModulating neuronal excitability
Parkinson’s DiseaseRegulating motor function
Drug AddictionInfluencing reward pathways

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order remarks for customized preparation.
Lead Time
Delivery times vary depending on the purchase method and location. Please contact your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a reference.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized forms have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquoting is essential for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us, and we will prioritize its development.
Synonyms
Kcnj6; Girk2; Kcnj7; W; G protein-activated inward rectifier potassium channel 2; GIRK-2; Inward rectifier K(+ channel Kir3.2; Potassium channel, inwardly rectifying subfamily J member 6
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-425
Protein Length
Full length protein
Species
Mus musculus (Mouse)
Target Names
Target Protein Sequence
MTMAKLTESMTNVLEGDSMDQDVESPVAIHQPKLPKQARDDLPRHISRDRTKRKIQRYVR KDGKCNVHHGNVRETYRYLTDIFTTLVDLKWRFNLLIFVMVYTVTWLFFGMIWWLIAYIR GDMDHIEDPSWTPCVTNLNGFVSAFLFSIETETTIGYGYRVITDKCPEGIILLLIQSVLG SIVNAFMVGCMFVKISQPKKRAETLVFSTHAVISMRDGKLCLMFRVGDLRNSHIVEASIR AKLIKSKQTSEGEFIPLNQSDINVGYYTGDDRLFLVSPLIISHEINQQSPFWEISKAQLP KEELEIVVILEGIVEATGMTCQARSSYITSEILWGYRFTPVLTMEDGFYEVDYNSFHETY ETSTPSLSAKELAELANRAEVPLSWSVSSKLNQHAELETEEEEKNPEELTERNGDVANLE NESKV
Uniprot No.

Target Background

Function

This G protein-regulated potassium channel plays a role in granule cell differentiation, potentially through membrane hyperpolarization. Inward rectifier potassium channels are characterized by a greater influx of potassium ions compared to efflux. Their voltage dependence is modulated by extracellular potassium concentration; increasing external potassium shifts the channel opening voltage range to more positive potentials. Inward rectification is primarily attributed to internal magnesium blockage of outward current.

Gene References Into Functions
  1. GIRK2 isoform balance within neurons affects the processing of afferent inhibitory input and associated behavior. PMID: 28487514
  2. Locomotor activity in mice remained unchanged compared to GIRK2(floxed) mice in open-field tests. PMID: 29180115
  3. G protein-coupled inwardly rectifying K+ (GIRK) 2 subunit-containing channels significantly regulate the properties and inhibitory activity of dorsal raphe neurons, suggesting their potential relevance in affective disorder research. PMID: 28196855
  4. Increased Kcnj6 gene dosage is linked to synaptic and cognitive dysfunction in a Down Syndrome animal model. PMID: 28342823
  5. The GABABR-coupled GIRK2 channel is crucial for the GABABR agonist-induced infantile spasms phenotype in the Ts mouse model, highlighting its potential as a therapeutic target for infantile spasms in Down syndrome. PMID: 27462820
  6. GIRK2, through its dual responsiveness to G protein beta-gamma and Na+, mediates a type of neuronal inhibition that's amplified under conditions of excessive electrical activity. PMID: 27074662
  7. While cholesterol didn't affect the unitary conductance of GIRK2, it significantly increased the frequency of channel openings. PMID: 28213520
  8. GIRK channels composed of GIRK2 subunits influence depression-related behaviors and basal and 5-HT1A receptor-mediated dorsal raphe neuronal activity. PMID: 25956878
  9. Spontaneous GIRK2 mutations causing cerebellar pathology impair motor function during the neonatal period. PMID: 25907855
  10. Serine 196 in Kir3.2 is involved in PKC-mediated channel inhibition. PMID: 26490875
  11. Ventral tegmental area GABA neurons express GIRK2 (and GIRK1) subunits. PMID: 25948263
  12. Simultaneous presence of Gbeta-gamma and PIP2 is required for GIRK2 activation. PMID: 25049222
  13. Ligand-operated activation of Kir3.2 causes dilation of the cytoplasmic domain pore, regulated conformationally. PMID: 24244570
  14. A subcellular GIRK2c/GIRK3 pathway regulates ventral tegmental area dopamine neuron excitability. PMID: 24811384
  15. Girk2 gene mutation alters the in vivo electrical activity of LC neurons. PMID: 23040084
  16. These findings elucidate the developmental regulation of GIRK channels in the cerebellum. PMID: 23261870
  17. In the developing rat dorsal horn, K(ir)3.1 and K(ir)3.2 are expressed at mature levels from birth. PMID: 23219908
  18. GIRK2 mediates the mGluR-sensitive current in unipolar brush cells. PMID: 22528965
  19. GIRK2 is expressed in almost all human pigmented neurons or mouse tyrosine hydroxylase-immunoreactive neurons in the substantia nigra and ventral tegmental areas. PMID: 22252428
  20. Biophysical analysis of the inwardly rectifying channel, Kir3.2, conductance properties. PMID: 23022491
  21. GIRK modulation involves channel assembly with R7-RGS/Gbeta5 complexes under allosteric control of R7 RGS-binding protein (R7BP). PMID: 23169654
  22. Kcnj6 gene expression in the mouse dorsal raphe nucleus. PMID: 22534482
  23. This study describes the developmental regulation and subcellular diversity of neuronal GIRK/Kir3 channels, supporting the idea that distinct GIRK channel subpopulations exert separate effects on neuronal excitability. PMID: 22098295
  24. Studies in two mammalian species suggest a conserved mechanism by which GIRK2 inward-rectifying K(+) ion channels support sperm function during fertilization. PMID: 22054410
  25. The mechanisms of GIRK regulation by Galpha(i/o) using wild-type Galpha(i3) (Galpha(i3)WT) and Galpha(i3) were investigated. PMID: 21795707
  26. Altered neurotransmission in the limbic system of Girk2 knockout mice involves secondary adaptations that enhance glutamatergic signaling. PMID: 20557431
  27. GIRK2 knockout mice exhibit a transient hyperactive phenotype, initially showing high motor activity and slower habituation, increased spontaneous locomotion during the dark phase, and impaired habituation in the open-field test. PMID: 11823889
  28. Activation involved in analgesia mechanisms. PMID: 12493843
  29. Contributes to channel-mediated postsynaptic signaling in opiate and alpha 2-adrenergic analgesia and analgesic sex differences. PMID: 12496346
  30. Results do not support the idea that the Kir3.2 potassium channel mediates the immobilizing effects of inhaled anesthetics. PMID: 12707131
  31. Native dopamine neuron wvGIRK2 channels are not Ca2+ permeable; when activated by D@ and GABAB receptors, they mediate depolarization through VGCC channels. PMID: 15240766
  32. Kir3.2-containing K+ channels on dendritic spines preferentially mediate the effects of GABA. PMID: 16624949
  33. Ts65Dn mice with Girk2 mutations show significantly increased hypothermic responses to 8-OH-DPAT, a serotonin receptor agonist. PMID: 16708025
  34. GIRK2 overexpression may negatively affect cerebellar circuitry in the Down syndrome animal model's vestibulocerebellum and dorsal cochlear nucleus. PMID: 16783527
  35. Increased expression of GIRK2-containing channels has functional consequences that likely affect the balance between excitatory and inhibitory neuronal transmission. PMID: 17093127
  36. GIRK2 showed the most widespread and robust labeling in the cerebellum, particularly prominent in granule cells, Purkinje neurons, Golgi cells, and unipolar brush cells. PMID: 18088366
  37. Inhibition of adrenergic tone is necessary for dependence induction; channels containing GIRK2 and GIRK3 act as inhibitory gates. PMID: 18400906
  38. This study describes opioid-induced postsynaptic inhibition in locus coeruleus neurons from wild-type and GIRK2/GIRK3(-/-) mice at baseline and after chronic morphine treatment. PMID: 18702733
  39. Comparison of high-resolution inwardly rectifying K(+) channel structures suggests a model for GIRK channel activation using a hydrophobic alcohol-binding pocket. PMID: 19561601
Database Links
Involvement In Disease
Defects in Kcnj6 are the cause of the weaver (wv) phenotype. Homozygous animals suffer from severe ataxia that is obvious by about the second postnatal week. The cerebellum of these animals is drastically reduced in size due to depletion of the major cell type of cerebellum, the granule cell neuron. Heterozygous animals are not ataxic but have an intermediate number of surviving granule cells. Male homozygotes are sterile, because of complete failure of sperm production. Both hetero- and homozygous animals undergo sporadic tonic-clonic seizures.
Protein Families
Inward rectifier-type potassium channel (TC 1.A.2.1) family, KCNJ6 subfamily
Subcellular Location
Membrane; Multi-pass membrane protein.
Tissue Specificity
Cerebellum, testes, cortex and substentia nigra.

Q&A

What are the alternative names and identifiers for mouse Kcnj6?

Mouse G protein-activated inward rectifier potassium channel 2 is encoded by the Kcnj6 gene and is also known by several alternative names including Girk2, Kcnj7, W, wv, BIR1, KATP2, Kir3.2, and weaver . These nomenclature variations appear throughout the scientific literature, and researchers should be aware of all identifiers when conducting comprehensive literature searches. The human ortholog is designated as KCNJ6/GIRK2 with similar alternative names (BIR1, GIRK2, KATP2, KCNJ7, GIRK-2, KATP-2, KIR3.2, hiGIRK2) .

What is the basic structure and function of Kcnj6 channels?

Kcnj6 encodes an inwardly rectifying potassium channel that is activated by G-protein signaling. These channels function as critical effectors in determining the degree of analgesia experienced upon opioid receptor activation by both endogenous and exogenous opioids . Experimentally, researchers can study channel function through electrophysiological techniques that measure potassium currents in response to G-protein coupled receptor activation. When designing structure-function studies, it is important to consider both the membrane-spanning domains and the cytoplasmic regions involved in G-protein interactions.

What expression systems are recommended for recombinant mouse Kcnj6 production?

Multiple expression systems are available for recombinant mouse Kcnj6 production, including E. coli, yeast, baculovirus, and mammalian cell expression systems . Each system offers distinct advantages:

Expression SystemAdvantagesLimitationsTypical Applications
E. coliHigh yield, low cost, rapidLimited post-translational modificationsStructural studies, antibody production
YeastEukaryotic modifications, moderate yieldMore complex than bacterial systemsFunctional studies with some modifications
BaculovirusNear-native modifications, high yieldHigher cost, longer production timeFunctional assays, complex interaction studies
Mammalian CellsNative-like modificationsHighest cost, lower yieldTrafficking studies, physiological assays
Cell-Free ExpressionRapid, controlled conditionsLimited modificationsScreening, initial characterization

For physiologically relevant studies, mammalian expression systems are preferred despite their higher cost, as they provide proper post-translational modifications and trafficking .

What purification methods yield the highest functional activity of recombinant Kcnj6?

Recombinant mouse Kcnj6 is typically purified to ≥85% purity as determined by SDS-PAGE . The purification strategy should be designed based on the expression system and downstream applications. For functional studies, gentler purification methods that preserve native conformation are recommended over those that maximize yield. When using affinity tags, researchers should verify that the tag position does not interfere with channel assembly or function.

What mouse models are available for studying Kcnj6 in vivo?

The weaver mouse (wv) represents a naturally occurring Kcnj6 mutation model . This model exhibits neurological phenotypes related to Kcnj6 dysfunction. Additionally, researchers have developed various transgenic and knockout models targeting specific aspects of Kcnj6 function. When selecting an appropriate model, consider whether you need to study:

  • Complete loss of Kcnj6 function

  • Specific mutations corresponding to human polymorphisms

  • Tissue-specific alterations in expression

  • Altered regulation of the channel

What antibody-based techniques are effective for Kcnj6 detection and characterization?

Multiple antibody-based techniques are applicable for Kcnj6 research including Western blot, immunohistochemistry, flow cytometry, and ELISA . For optimal results:

  • Western blot: Use affinity-purified antibodies with careful validation against knockout controls.

  • Immunohistochemistry (IHC): Paraffin-embedded tissues require optimized antigen retrieval.

  • Flow cytometry: Particularly useful for cell surface expression studies.

  • FLISA/ELISA: Available commercial kits demonstrate high specificity for both human and mouse variants .

Appropriate controls should include tissues or cells lacking Kcnj6 expression to confirm antibody specificity.

What electrophysiological approaches are optimal for functional characterization of Kcnj6 channels?

Patch-clamp electrophysiology remains the gold standard for functional characterization of ion channels including Kcnj6. For G-protein coupled inwardly rectifying potassium channels:

  • Whole-cell recordings: Useful for measuring macroscopic currents and drug responses.

  • Single-channel recordings: Provide detailed kinetic information about channel gating.

  • Inside-out patches: Allow direct application of G-proteins to the intracellular face.

When designing electrophysiological experiments, account for the following considerations:

  • Appropriate internal and external solutions mimicking physiological ionic conditions

  • Temperature control (as channel kinetics are temperature-dependent)

  • Methods for activating G-protein signaling (receptor agonists or direct G-protein application)

How can RNA interference be utilized to study Kcnj6 function?

RNA interference techniques using siRNA targeting Kcnj6/KCNJ6 are commercially available with >97% purity . For effective knockdown:

  • Design experiments with appropriate controls including scrambled siRNA sequences.

  • Validate knockdown efficiency at both mRNA (qPCR) and protein (Western blot) levels.

  • Consider temporal aspects of knockdown in relation to the functional readout being measured.

  • Account for potential compensation by other related channels (especially other GIRK family members).

How do Kcnj6 polymorphisms affect pain sensitivity and analgesic responses?

Research has established associations between KCNJ6 gene polymorphisms and both acute and chronic pain phenotypes . A tag SNP approach was used to comprehensively examine pain-related effects of KCNJ6 genes in relation to post-surgical pain phenotypes and opioid analgesic requirements . For studying such associations:

  • Use tag SNP approaches to capture maximum genetic variation with minimal redundancy.

  • Consider both acute experimental pain models and clinical pain phenotypes.

  • Account for population stratification in genetic association studies.

  • Analyze haplotypes rather than isolated SNPs when possible.

What methodologies are recommended for genotype-phenotype correlation studies involving Kcnj6?

For robust genotype-phenotype studies, researchers have successfully employed:

  • Laboratory acute pain response phenotyping using standardized protocols like the ischemic forearm pain task .

  • Chronic pain assessment using validated visual analog scales for both intensity and unpleasantness dimensions .

  • Post-surgical pain phenotyping through quantification of analgesic medication requirements .

  • Careful subject selection with appropriate inclusion/exclusion criteria to minimize confounding factors.

When designing such studies, limit analyses to specific ethnic groups (e.g., Caucasian subjects) to reduce population substructure influences .

What advanced statistical approaches are recommended for Kcnj6 genetic association studies?

Complex genetic associations require sophisticated statistical approaches:

  • Account for multiple testing through appropriate corrections (Bonferroni, FDR).

  • Consider gene-gene and gene-environment interactions in modeling.

  • Use replication cohorts to validate initial findings .

  • Apply pathway analysis to contextualize findings within biological networks.

For pain phenotypes specifically, multivariate approaches that incorporate multiple dimensions of the pain experience (intensity, unpleasantness, threshold, tolerance) provide more comprehensive understanding than univariate analyses .

How can researchers investigate Kcnj6 interactions with other proteins?

G protein-activated inward rectifier potassium channels function within complex signaling networks. To study protein-protein interactions:

  • Co-immunoprecipitation with carefully validated antibodies for pull-down assays.

  • Proximity ligation assays for detecting in situ protein interactions.

  • FRET/BRET approaches for studying dynamic interactions in living cells.

  • Split-protein complementation assays for confirming direct interactions.

When investigating G-protein interactions specifically, consider using purified G-protein subunits in reconstitution studies or activating endogenous G-proteins through receptor stimulation.

What approaches can differentiate between direct and indirect modulators of Kcnj6 function?

Distinguishing direct channel modulators from those affecting upstream signaling requires carefully designed experiments:

  • Inside-out patch recordings with direct application of test compounds to isolated membrane patches.

  • Heterologous expression systems with defined components to eliminate confounding factors.

  • Binding assays with purified recombinant Kcnj6 protein.

  • Structural studies using techniques like hydrogen-deuterium exchange mass spectrometry to identify binding sites.

Include positive controls (known direct modulators) and negative controls (compounds affecting upstream signaling) in experimental designs.

How do Kcnj6 channels contribute to neuronal excitability in pain pathways?

GIRK channels including Kcnj6 serve as critical effectors determining the degree of analgesia experienced upon opioid receptor activation . For investigating these mechanisms:

  • Use electrophysiological recordings in native neurons from pain processing regions.

  • Combine with pharmacological tools that selectively modulate Kcnj6 function.

  • Consider both pre- and post-synaptic effects on circuit function.

  • Incorporate calcium imaging to assess downstream consequences of altered excitability.

What high-throughput screening approaches can identify novel Kcnj6 modulators?

For drug discovery applications targeting Kcnj6:

  • Fluorescence-based membrane potential assays in cell lines stably expressing Kcnj6.

  • Automated electrophysiology platforms for direct functional assessment.

  • Binding assays using purified recombinant protein.

  • In silico screening based on channel structure followed by experimental validation.

Design counter-screens to assess selectivity against other potassium channels, particularly other GIRK family members.

How can Kcnj6 research contribute to pain management therapeutic development?

The established role of KCNJ6 in pain phenotypes makes it a valuable therapeutic target . Research approaches include:

  • Screening for selective Kcnj6 modulators that enhance channel function.

  • Development of compounds that positively modulate specific GIRK heteromers involved in pain pathways.

  • Investigation of genetic variants that predict analgesic efficacy or risk of adverse effects.

  • Development of personalized medicine approaches based on KCNJ6 genotype.

What are the methodological considerations for translating Kcnj6 research from mouse to human applications?

Translational research requires careful consideration of species differences:

  • Compare pharmacological profiles between mouse Kcnj6 and human KCNJ6.

  • Validate findings in humanized mouse models where possible.

  • Correlate mouse findings with human genetic association studies.

  • Consider differences in tissue distribution and splice variant expression between species.

A tag SNP approach similar to that used in human studies can be adapted for mouse models to ensure comparable genetic coverage .

How should researchers normalize Kcnj6 expression data across different experimental systems?

When comparing Kcnj6 expression across different contexts:

  • Use multiple reference genes for qPCR normalization, selected based on expression stability.

  • For protein quantification, normalize to total protein rather than single "housekeeping" proteins.

  • Include calibration standards across experiments to allow inter-experimental comparisons.

  • Report both absolute and relative quantification when possible.

What approaches help resolve contradictory findings in Kcnj6 functional studies?

Contradictions in the literature may arise from methodological differences:

  • Carefully document experimental conditions including expression system, temperature, and ionic conditions.

  • Consider splice variant differences between studies.

  • Account for heteromeric channel assembly with other GIRK subunits.

  • Evaluate species differences when comparing across studies.

When replicating previous work, match experimental conditions as closely as possible while documenting any necessary deviations.

How can researchers integrate electrophysiological, genetic, and behavioral data in Kcnj6 studies?

Multi-modal data integration requires sophisticated approaches:

  • Develop computational models linking channel biophysics to cellular excitability.

  • Use pathway analysis to connect molecular changes to behavioral outcomes.

  • Apply systems biology approaches to contextualize findings within broader biological networks.

  • Consider both direct effects of Kcnj6 function and compensatory mechanisms that may emerge.

For pain phenotypes specifically, correlate laboratory acute pain measures with clinical pain outcomes when possible, as demonstrated in studies examining associations between KCNJ6 polymorphisms and both experimental and clinical pain measures .

What emerging technologies show promise for advancing Kcnj6 research?

Cutting-edge approaches with potential for Kcnj6 research include:

  • Cryo-EM structural studies of native channel complexes.

  • CRISPR-Cas9 gene editing for precise manipulation of endogenous channels.

  • All-optical electrophysiology combining optogenetics and voltage imaging.

  • Single-cell transcriptomics to characterize cell-type specific expression patterns.

How might Kcnj6 research extend beyond pain to other neurological functions?

While pain mechanisms are well-studied , Kcnj6 channels have broader neurological relevance:

  • Investigate roles in neurodevelopmental disorders (suggested by the weaver mouse phenotype) .

  • Explore contributions to neuronal excitability in epilepsy models.

  • Examine potential roles in substance use disorders, given interactions with opioid signaling .

  • Study involvement in neurodegenerative conditions through regulation of neuronal excitability.

What standardization efforts could advance comparative Kcnj6 research?

To enhance reproducibility and cross-study comparisons:

  • Develop standardized electrophysiological protocols specific to GIRK channels.

  • Establish validated reference materials (antibodies, recombinant proteins, cell lines).

  • Create centralized databases for Kcnj6 genetic variants and associated phenotypes.

  • Adopt common nomenclature and reporting standards for consistent literature.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.